Feasibility of Intraperitoneal Chemotherapy in the Surgical Treatment of Colon Cancer cT4

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

January 9, 2018

Primary Completion Date

August 5, 2020

Study Completion Date

August 10, 2020

Conditions
Colon Cancer
Interventions
PROCEDURE

Experimental group

After performing the surgical intervention, the patient will undergo intraoperative intra-abdominal chemotherapy with mitomycin C. Further, lavage of the abdominal cavity will be repeated, followed by immunological examination.

PROCEDURE

Control group

In the control group (40 patients), after laparotomy and revision, peritoneal lavage will also be performed with subsequent immunological examination. Patients of this group will not receive intraperitoneal chemotherapy. After performing the surgical intervention, the patient will be irrigation of the abdominal cavity with physiological saline. Further, lavage of the abdominal cavity will be repeated, followed by immunological examination.

Trial Locations (1)

123423

State Scientific Centre of Coloproctology, Moscow

All Listed Sponsors
lead

State Scientific Centre of Coloproctology, Russian Federation

OTHER_GOV

NCT03561948 - Feasibility of Intraperitoneal Chemotherapy in the Surgical Treatment of Colon Cancer cT4 | Biotech Hunter | Biotech Hunter